Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Kebomed AS
AS
Active
Org 941668844
Midtunhaugen 17, 5224
Nesttun
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1986 · 39 years old
27 employees
www.kebomed.no
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Kebomed AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
196M
147M
98M
49M
0M
2021: 103M
103M
2021
2022: 98M (-5% vs 2021)
98M
-5%
2022
2023: 106M (+8% vs 2022)
106M
+8%
2023
2024: 123M (+16% vs 2023)
123M
+16%
2024
2025: 157M (+28% vs 2024)
157M
+28%
2025
EBITDA
NOK millions
19M
14M
9M
5M
0M
2021: 15M
15M
2021
2022: 9M (-40% vs 2021)
9M
-40%
2022
2023: 10M (+11% vs 2022)
10M
+11%
2023
2024: 10M (0% vs 2023)
10M
0%
2024
2025: 7M (-30% vs 2024)
7M
-30%
2025
Income statement
NOK thousands
Item
2025
2024
2023
2022
2021
Revenue
156 677
123 402
106 171
97 938
103 473
Staff expenses
−27 226
−24 565
−21 832
−19 398
−19 051
EBITDA
6 946
9 948
9 906
8 700
15 370
Depreciation & amort.
−5
−0
−0
−0
−0
EBIT
6 940
9 948
9 906
8 700
15 370
Net financials
571
874
−1 571
−263
473
Profit before tax
7 511
10 822
8 335
8 437
15 843
Tax
1 817
2 348
1 604
2 004
2 401
Net profit
5 694
8 474
6 732
6 433
13 442
Balance sheet
NOK thousands
Item
2025
2024
2023
2022
2021
Total assets
74 680
70 519
59 233
44 384
43 803
Equity
34 623
34 623
26 150
19 418
12 985
Long-term debt
0
0
0
0
0
Short-term debt
40 056
35 896
33 084
24 427
29 742
Total debt
40 056
35 896
33 084
24 427
29 742
Financial ratios
5-year trend
EBITDA margin
4,4 %
This company
15,8 %
Market median
This company
Market median
72% below market
2021
2025
Equity ratio
46,4 %
This company
38,2 %
Market median
This company
Market median
21% above market
2021
2025
Return on equity
16,4 %
This company
18,4 %
Market median
This company
Market median
11% below market
2021
2025
Net profit margin
3,6 %
This company
8,1 %
Market median
This company
Market median
56% below market
2021
2025
Asset turnover
2,10×
This company
1,12×
Market median
This company
Market median
87% above market
2021
2025
Debt / equity
1,16×
This company
0,62×
Market median
This company
Market median
87% above market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Brønnøysundsregistrene · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2020-07-01 – 2021-06-30
View
PDF
More on Kebomed AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
